BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23244626)

  • 1. Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar development.
    Offman E; Edginton AN
    Xenobiotica; 2013 Jun; 43(6):561-9. PubMed ID: 23244626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited.
    Wang W; Prueksaritanont T
    Biopharm Drug Dispos; 2010 May; 31(4):253-63. PubMed ID: 20437464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interspecies scaling of therapeutic monoclonal antibodies: initial look.
    Ling J; Zhou H; Jiao Q; Davis HM
    J Clin Pharmacol; 2009 Dec; 49(12):1382-402. PubMed ID: 19837907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interspecies allometric scaling. Part I: prediction of clearance in large animals.
    Mahmood I; Martinez M; Hunter RP
    J Vet Pharmacol Ther; 2006 Oct; 29(5):415-23. PubMed ID: 16958787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interspecies allometric scaling: prediction of clearance in large animal species: part II: mathematical considerations.
    Martinez M; Mahmood I; Hunter RP
    J Vet Pharmacol Ther; 2006 Oct; 29(5):425-32. PubMed ID: 16958788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of hybrid approach based on empirical and physiological concept for predicting pharmacokinetics in humans--usefulness of exponent on prospective evaluation of predictability.
    Sayama H; Komura H; Kogayu M
    Drug Metab Dispos; 2013 Feb; 41(2):498-507. PubMed ID: 23209193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of human pharmacokinetics of therapeutic monoclonal antibodies from simple allometry of monkey data.
    Oitate M; Masubuchi N; Ito T; Yabe Y; Karibe T; Aoki T; Murayama N; Kurihara A; Okudaira N; Izumi T
    Drug Metab Pharmacokinet; 2011; 26(4):423-30. PubMed ID: 21606605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR.
    Morris ME; Yang X; Gandhi YA; Bhansali SG; Benincosa LJ
    Biopharm Drug Dispos; 2012 Jan; 33(1):1-14. PubMed ID: 22170504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs.
    Huh Y; Smith DE; Feng MR
    Xenobiotica; 2011 Nov; 41(11):972-87. PubMed ID: 21892879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interspecies scaling of a camptothecin analogue: human predictions for intravenous topotecan using animal data.
    Ahlawat P; Srinivas NR
    Xenobiotica; 2008 Nov; 38(11):1377-85. PubMed ID: 18946781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies Scaling of Antibody-Drug Conjugates (ADC) for the Prediction of Human Clearance.
    Mahmood I
    Antibodies (Basel); 2021 Jan; 10(1):. PubMed ID: 33430196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interspecies scaling of biliary excreted drugs: a comparison of several methods.
    Mahmood I
    J Pharm Sci; 2005 Apr; 94(4):883-92. PubMed ID: 15736194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
    Mahmood I
    Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing first-in-human dose of coagulation factors: application of pharmacokinetic allometric scaling.
    Mahmood I
    Haemophilia; 2014 Jan; 20(1):32-8. PubMed ID: 23855969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-species approach considering additional physiological information for prediction of hepatic clearance of glycoprotein derivate therapeutics.
    Poulin P
    Clin Pharmacokinet; 2011 Oct; 50(10):665-74. PubMed ID: 21895038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interspecies scaling of biliary excreted drugs.
    Mahmood I; Sahajwalla C
    J Pharm Sci; 2002 Aug; 91(8):1908-14. PubMed ID: 12115817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humans.
    Nagilla R; Ward KW
    J Pharm Sci; 2004 Oct; 93(10):2522-34. PubMed ID: 15349961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?
    Deng R; Iyer S; Theil FP; Mortensen DL; Fielder PJ; Prabhu S
    MAbs; 2011; 3(1):61-6. PubMed ID: 20962582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches for predicting human pharmacokinetics using interspecies pharmacokinetic scaling.
    Kang HE; Lee MG
    Arch Pharm Res; 2011 Nov; 34(11):1779-88. PubMed ID: 22139680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.